Literature DB >> 22700315

Galectin labeling of cells from paraffinized tissues may serve as a diagnostic tool in the detection and classification of thyroid carcinomas.

Rebeca Palacios-Corona1, Francisco González-Salazar, Ricardo M Cerda-Flores, Javier Vargas-Villarreal, Eduardo González-Murillo, Hugo Gutiérrez-Hermosillo, Hugo Gómez-Rueda, Lorena Tamez-Peña, Gerardo Rivera-Silva, Héctor Eloy Tamez-Pérez.   

Abstract

This study seeks to determine whether the relative levels of attachment to galectins 1 and 3 of cells from thyroid tissues embedded in paraffin blocks can differentiate thyroid tumors from normal tissues. A total of 48 thyroid paraffin sample blocks from 4 groups of patients were analyzed: 12 samples served as controls, 12 samples were from patients with thyroid adenoma, 12 samples were from patients with thyroid follicular carcinoma, and 12 samples were from patients with thyroid papillary carcinoma. The relative attachment of cells to galectins 1 and 3 antigens was determined using the InnoCyte™ ECM Cell Adhesion kit at different cell sample concentrations. All of the samples from thyroid tissue preparations showed attachment to galectins 1 and 3. The samples from tissues with a diagnosis of adenoma, follicular and papillary carcinoma showed an increased adherence to galectins 1 and 3 relative to the controls. Significant differences were found between the means of the adherent cells from the adenomas compared with the follicular and papillary carcinoma samples. When the outcomes from the galectins 1 and 3 cell surface binding were compared, no statistical differences were found. The cells from adenoma and carcinoma samples show more adhesion to galectins 1 and 3 than cells from the control samples. The samples prepared from follicular and papillary carcinomas show more cells adherent to galectins 1 and 3 than those from the adenomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22700315     DOI: 10.1007/s12022-012-9215-x

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  36 in total

Review 1.  Introduction to galectins.

Authors:  Hakon Leffler; Susanne Carlsson; Maria Hedlund; Yuning Qian; Francoise Poirier
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 2.  Intracellular functions of galectins.

Authors:  Fu-Tong Liu; Ronald J Patterson; John L Wang
Journal:  Biochim Biophys Acta       Date:  2002-09-19

3.  Galectins in regulation of apoptosis.

Authors:  Fu-Tong Liu; Ri-Yao Yang; Jun Saegusa; Huan-Yuan Chen; Daniel K Hsu
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

4.  Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors.

Authors:  Tijana Išić; Svetlana Savin; Dubravka Cvejić; Ilona Marečko; Svetislav Tatić; Marija Havelka; Ivan Paunović
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-04       Impact factor: 4.553

Review 5.  Galectin-1: a small protein with major functions.

Authors:  Isabelle Camby; Marie Le Mercier; Florence Lefranc; Robert Kiss
Journal:  Glycobiology       Date:  2006-07-13       Impact factor: 4.313

6.  Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.

Authors:  P L Fernández; M J Merino; M Gómez; E Campo; T Medina; V Castronovo; X Sanjuán; A Cardesa; F T Liu; M E Sobel
Journal:  J Pathol       Date:  1997-01       Impact factor: 7.996

7.  Novel fluorescent glycan microarray strategy reveals ligands for galectins.

Authors:  Xuezheng Song; Baoyun Xia; Sean R Stowell; Yi Lasanajak; David F Smith; Richard D Cummings
Journal:  Chem Biol       Date:  2009-01-30

8.  Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors.

Authors:  Luciane Martins; Sílvia E Matsuo; Kátia N Ebina; Marco Aurélio V Kulcsar; Celso U M Friguglietti; Edna T Kimura
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

9.  Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.

Authors:  X C Xu; A K el-Naggar; R Lotan
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

10.  Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis.

Authors:  J E Barroeta; Z W Baloch; P Lal; T L Pasha; P J Zhang; V A LiVolsi
Journal:  Endocr Pathol       Date:  2006       Impact factor: 4.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.